{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:53Z","timestamp":1791331613044,"version":"4.3.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>Most non-Hodgkin lymphomas (NHLs) are of B-cell origin, but the tumor tissue can be variably infiltrated with T cells. In the present study, we have identified a subset of CD4+CD25+ T cells with high levels of CTLA-4 and Foxp3 (intratumoral Treg cells) that are overrepresented in biopsy specimens of B-cell NHL (median of 17% in lymphoma biopsies, 12% in inflammatory tonsil, and 6% in tumor-free lymph nodes; P = .001). We found that these CD4+CD25+ T cells suppressed the proliferation and cytokine (IFN-\u03b3 and IL-4) production of infiltrating CD4+CD25- T cells in response to PHA stimulation. PD-1 was found to be constitutively and exclusively expressed on a subset of infiltrating CD4+CD25- T cells, and B7-H1 could be induced on intratumoral CD4+CD25+ T cells in B-cell NHL. Anti-B7-H1 antibody or PD-1 fusion protein partly restored the proliferation of infiltrating CD4+CD25- T cells when cocultured with intratumoral Treg cells. Finally, we found that CCL22 secreted by lymphoma B cells is involved in the chemotaxis and migration of intratumoral Treg cells that express CCR4, but not CCR8. Taken together, our results suggest that Treg cells are highly represented in the area of B-cell NHL and that malignant B cells are involved in the recruitment of these cells into the area of lymphoma.<\/jats:p>","DOI":"10.1182\/blood-2005-08-3376","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T01:48:50Z","timestamp":1136944130000},"page":"3639-3646","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":370,"title":["Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma"],"prefix":"10.1182","volume":"107","author":[{"given":"Zhi-Zhang","family":"Yang","sequence":"first","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Stenson","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902482294100_REF1","doi-asserted-by":"crossref","unstructured":"de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol. 2005;23: 6358-6363.","DOI":"10.1200\/JCO.2005.26.856"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Drach J, Seidl S, Kaufmann H. Treatment of mantle cell lymphoma: targeting the microenvironment. Expert Rev Anticancer Ther. 2005;5: 477-485.","DOI":"10.1586\/14737140.5.3.477"},{"key":"2019111902482294100_REF3","doi-asserted-by":"crossref","unstructured":"Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351: 2159-2169.","DOI":"10.1056\/NEJMoa041869"},{"key":"2019111902482294100_REF4","doi-asserted-by":"crossref","unstructured":"Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE. Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol. 2001;19: 720-726.","DOI":"10.1200\/JCO.2001.19.3.720"},{"key":"2019111902482294100_REF5","doi-asserted-by":"crossref","unstructured":"Baecher-Allan C, Viglietta V, Hafler DA. Human CD4+CD25+ regulatory T cells. Semin Immunol. 2004;16: 89-98.","DOI":"10.1016\/j.smim.2003.12.005"},{"key":"2019111902482294100_REF6","doi-asserted-by":"crossref","unstructured":"Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002;2: 389-400.","DOI":"10.1038\/nri821"},{"key":"2019111902482294100_REF7","doi-asserted-by":"crossref","unstructured":"Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol. 2001;2: 816-822.","DOI":"10.1038\/ni0901-816"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001; 182: 18-32.","DOI":"10.1034\/j.1600-065X.2001.1820102.x"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol. 2003;15: 690-696.","DOI":"10.1016\/j.coi.2003.09.011"},{"key":"2019111902482294100_REF10","doi-asserted-by":"crossref","unstructured":"Piccirillo CA, Shevach EM. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol. 2004;16: 81-88.","DOI":"10.1016\/j.smim.2003.12.003"},{"key":"2019111902482294100_REF11","doi-asserted-by":"crossref","unstructured":"Curotto de Lafaille MA, Lafaille JJ. CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol. 2002;14: 771-778.","DOI":"10.1016\/S0952-7915(02)00408-9"},{"key":"2019111902482294100_REF12","doi-asserted-by":"crossref","unstructured":"Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol. 2003;81: 331-371.","DOI":"10.1016\/S0065-2776(03)81008-8"},{"key":"2019111902482294100_REF13","doi-asserted-by":"crossref","unstructured":"Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299: 1057-1061.","DOI":"10.1126\/science.1079490"},{"key":"2019111902482294100_REF14","doi-asserted-by":"crossref","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4: 330-336.","DOI":"10.1038\/ni904"},{"key":"2019111902482294100_REF15","doi-asserted-by":"crossref","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4: 337-342.","DOI":"10.1038\/ni909"},{"key":"2019111902482294100_REF16","doi-asserted-by":"crossref","unstructured":"Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med. 2002; 196: 247-253.","DOI":"10.1084\/jem.20020642"},{"key":"2019111902482294100_REF17","doi-asserted-by":"crossref","unstructured":"Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 2002;196: 255-260.","DOI":"10.1084\/jem.20020394"},{"key":"2019111902482294100_REF18","doi-asserted-by":"crossref","unstructured":"Levings MK, Sangregorio R, Sartirana C, et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med. 2002;196: 1335-1346.","DOI":"10.1084\/jem.20021139"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med. 2002;196: 379-387.","DOI":"10.1084\/jem.20020110"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med. 2001;194: 629-644.","DOI":"10.1084\/jem.194.5.629"},{"key":"2019111902482294100_REF21","doi-asserted-by":"crossref","unstructured":"Piccirillo CA, Letterio JJ, Thornton AM, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med. 2002;196: 237-246.","DOI":"10.1084\/jem.20020590"},{"key":"2019111902482294100_REF22","doi-asserted-by":"crossref","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155: 1151-1164.","DOI":"10.4049\/jimmunol.155.3.1151"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int Immunol. 1998;10: 1969-1980.","DOI":"10.1093\/intimm\/10.12.1969"},{"key":"2019111902482294100_REF24","doi-asserted-by":"crossref","unstructured":"Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999;162: 5317-5326.","DOI":"10.4049\/jimmunol.162.9.5317"},{"key":"2019111902482294100_REF25","doi-asserted-by":"crossref","unstructured":"McHugh RS, Shevach EM. The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol. 2002;110: 693-702.","DOI":"10.1067\/mai.2002.129339"},{"key":"2019111902482294100_","unstructured":"Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 1999;59: 3128-3133."},{"key":"2019111902482294100_REF27","doi-asserted-by":"crossref","unstructured":"Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol. 1999;163: 5211-5218.","DOI":"10.4049\/jimmunol.163.10.5211"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med. 2001;194: 823-832.","DOI":"10.1084\/jem.194.6.823"},{"key":"2019111902482294100_REF29","unstructured":"Woo EY, Chu CS, Goletz TJ, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 2001;61: 4766-4772."},{"key":"2019111902482294100_REF30","doi-asserted-by":"crossref","unstructured":"Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 2002;169: 2756-2761.","DOI":"10.4049\/jimmunol.169.5.2756"},{"key":"2019111902482294100_REF31","unstructured":"Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003; 9: 4404-4408."},{"key":"2019111902482294100_REF32","unstructured":"Steitz J, Bruck J, Lenz J, Knop J, Tuting T. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res. 2001;61: 8643-8646."},{"key":"2019111902482294100_REF33","doi-asserted-by":"crossref","unstructured":"Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168: 4272-4276.","DOI":"10.4049\/jimmunol.168.9.4272"},{"key":"2019111902482294100_REF34","doi-asserted-by":"crossref","unstructured":"Viguier M, Lemaitre F, Verola O, et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173: 1444-1453.","DOI":"10.4049\/jimmunol.173.2.1444"},{"key":"2019111902482294100_REF35","doi-asserted-by":"crossref","unstructured":"Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10: 942-949.","DOI":"10.1038\/nm1093"},{"key":"2019111902482294100_REF36","doi-asserted-by":"crossref","unstructured":"Alvaro T, Lejeune M, Salvado MT, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res. 2005;11: 1467-1473.","DOI":"10.1158\/1078-0432.CCR-04-1869"},{"key":"2019111902482294100_REF37","doi-asserted-by":"crossref","unstructured":"Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2001;194: 847-853.","DOI":"10.1084\/jem.194.6.847"},{"key":"2019111902482294100_REF38","doi-asserted-by":"crossref","unstructured":"Dong H, Strome SE, Matteson EL, et al. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J Clin Invest. 2003;111: 363-370.","DOI":"10.1172\/JCI16015"},{"key":"2019111902482294100_REF39","doi-asserted-by":"crossref","unstructured":"Marshall NA, Christie LE, Munro LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood. 2004;103: 1755-1762.","DOI":"10.1182\/blood-2003-07-2594"},{"key":"2019111902482294100_REF40","doi-asserted-by":"crossref","unstructured":"Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer. 2003;98: 1089-1099.","DOI":"10.1002\/cncr.11618"},{"key":"2019111902482294100_REF41","doi-asserted-by":"crossref","unstructured":"Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol. 2002;169: 6210-6217.","DOI":"10.4049\/jimmunol.169.11.6210"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Nakamura K, Kitani A, Fuss I, et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004;172: 834-842.","DOI":"10.4049\/jimmunol.172.2.834"},{"key":"2019111902482294100_","doi-asserted-by":"crossref","unstructured":"Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000;192: 303-310.","DOI":"10.1084\/jem.192.2.303"},{"key":"2019111902482294100_REF44","doi-asserted-by":"crossref","unstructured":"Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000;192: 295-302.","DOI":"10.1084\/jem.192.2.295"},{"key":"2019111902482294100_REF45","doi-asserted-by":"crossref","unstructured":"Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001; 2: 1126-1132.","DOI":"10.1038\/ni735"},{"key":"2019111902482294100_REF46","doi-asserted-by":"crossref","unstructured":"Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175: 4180-4183.","DOI":"10.4049\/jimmunol.175.7.4180"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/9\/3639\/470021\/zh800906003639.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/9\/3639\/470021\/zh800906003639.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T04:40:00Z","timestamp":1683348000000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/9\/3639\/133501\/Intratumoral-CD4CD25-regulatory-Tcellmediated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3376","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}